These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1283241)

  • 1. [T-cell rich B-cell lymphoma associated with hemophagocytic syndrome].
    Dommann-Scherrer C; Zimmermann D; Hassam S; Odermatt BF; Risti B; Maurer R
    Verh Dtsch Ges Pathol; 1992; 76():122-5. PubMed ID: 1283241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
    Sawada M; Yamada T; Tsurumi H; Moriwaki H
    Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylactoid reaction to cyclophosphamide in a patient with T cell lymphoma and hemophagocytic syndrome.
    Minami R; Hirase N; Motomura S; Muta K; Nawata H; Nishimura J
    Int J Hematol; 1999 Jan; 69(1):57-8. PubMed ID: 10641445
    [No Abstract]   [Full Text] [Related]  

  • 4. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy.
    Dotti G; Stella CC; Mangoni L; Cottafavi L; Caramatti C; Almici C; Rizzoli V
    Haematologica; 1995; 80(2):142-5. PubMed ID: 7543069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
    Tarella C; Boccadoro M; Omedé P; Bondesan P; Caracciolo D; Frieri R; Bregni M; Siena S; Gianni AM; Pileri A
    Bone Marrow Transplant; 1993 Apr; 11(4):271-7. PubMed ID: 7683551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
    Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
    Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
    Dincol G; Agan M; Dogan O; Diz-Kucukkaya R; Uslu B
    Clin Lab Haematol; 2006 Dec; 28(6):419-22. PubMed ID: 17105497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSF.
    Vannucchi AM; Bosi A; Laszlo D; Guidi S; Saccardi R; Rossi-Ferrini P
    Haematologica; 1995; 80(4):341-3. PubMed ID: 7590505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
    Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
    Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
    Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
    Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
    Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
    Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angioimmunoblastic T-cell lymphoma associated with hemophagocytic syndrome at onset and relapse].
    Takai K; Sanada M
    Rinsho Ketsueki; 2000 Dec; 41(12):1260-6. PubMed ID: 11201151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic syndrome in ileum-origin B-cell lymphoma.
    Motegi S; Nishizaki Y; Muramatsu C; Nakamura H; Kobayashi F; Shiozawa H; Kamochi J; Itakura M; Shibuya M; Ogawa T; Matsuzaki S
    J Gastroenterol; 2003; 38(10):995-9. PubMed ID: 14614609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare variety of T-cell lymphoma.
    Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
    J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.
    Sung HJ; Kim SJ; Seo HY; Sul HR; Choi JG; Choi IK; Park KH; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Br J Haematol; 2006 Jul; 134(1):45-53. PubMed ID: 16803566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatosplenic B-cell lymphoma associated with hemophagocytic syndrome: a case report.
    Kwon SY; Lee JJ; Chung IJ; Kim HJ; Park MR; Kim HS; Park CS
    J Korean Med Sci; 1999 Dec; 14(6):671-4. PubMed ID: 10642947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
    Rossi G; Donisi A; Casari S; Re A; Stellini R; Cadeo G; Carosi G
    Haematologica; 1998 Apr; 83(4):317-22. PubMed ID: 9592981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.